What companies are 6848.TWO's competitors?

RBC Bioscience Corporation (6848.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does 6848.TWO compare to its peers?

The peer comparison table on this page shows RBC Bioscience Corporation (6848.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does 6848.TWO operate in?

RBC Bioscience Corporation (6848.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

6848.TWO

RBC Bioscience Corporation

TWO·Biotechnology · Healthcare

NT$24.15NT$0.65+2.77%

Market capNT$344.70M·Market closed·Aug 28 6:42 AM UTC

Frequently Asked Questions About 6848.TWO

What companies are 6848.TWO's competitors?: RBC Bioscience Corporation (6848.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 6848.TWO compare to its peers?: The peer comparison table on this page shows RBC Bioscience Corporation (6848.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 6848.TWO operate in?: RBC Bioscience Corporation (6848.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

6848.TWO

RBC Bioscience Corporation

TWO·Biotechnology · Healthcare

NT$24.15NT$0.65+2.77%

Market capNT$344.70M·Market closed·Aug 28 6:42 AM UTC

Peers


6662.TWO	BioLASCO Taiwan Co., Ltd.	NT$29.75	NT$762.0M
4170.TWO	Vectorite Biomedical Inc.	NT$12.70	NT$555.9M
6549.TWO	TaiwanJ Pharmaceuticals Co., Ltd.	NT$6.90	NT$552.8M
7607.TWO	DuoGenic StemCells corporation	NT$11.85	NT$434.3M
6621.TWO	UniPharma Co., Ltd.	NT$11.45	NT$412.6M
6797.TWO	Taiwan Advanced Nanotech Inc.	NT$12.00	NT$360.8M
4183.TWO	EPS Bio Technology Corp.	NT$14.00	NT$333.2M
4197.TWO	Visgeneer Inc.	NT$8.57	NT$258.7M
6734.TWO	iXensor Co., Ltd.	NT$6.00	NT$249.2M
6744.TWO	Feng Chi Biotech Corp.	NT$14.20	NT$218.7M

Frequently Asked Questions About 6848.TWO

What companies are 6848.TWO's competitors?: RBC Bioscience Corporation (6848.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 6848.TWO compare to its peers?: The peer comparison table on this page shows RBC Bioscience Corporation (6848.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 6848.TWO operate in?: RBC Bioscience Corporation (6848.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.